<it>POU1F1</it> is a novel fusion partner of <it>NUP98</it> in acute myeloid leukemia with t(3;11)(p11;p15)
Lisboa Susana, Cerveira Nuno, Bizarro Susana and 5 more
Molecular Cancer · 2013
doi:10.1186/1476-4598-12-5 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p><it>NUP98</it> gene rearrangements have been reported in acute myeloid leukemia, giving rise to fusion proteins that seem to function as aberrant transcription factors, and are thought to be associated with poor prognosis.</p> <p>Findings</p> <p>A patient with treatment-related acute myeloid leukemia presented a t(3;11)(p11;p15) as the only cytogenetic abnormality. FISH and molecular genetic analyses identified a class 1 homeobox gene, <it>POU1F1</it>, located on chromosome 3p11, as the fusion partner of <it>NUP98</it>. In addition, we have found that the patient harbored an <it>FLT3-ITD</it> mutation, which most likely collaborated with the <it>NUP98-POU1F1</it> fusion gene in malignant transformation.</p> <p>Conclusions</p> <p>We have identified <it>POU1F1</it> as the <it>NUP98</it> fusion partner in therapy-related AML with a t(3;11)(p11;p15). This is the first POU family member identified as a fusion partner in human cancer.</p>
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.